Activation of PAK by HIV and SIV Nef: Importance for AIDS in rhesus macaques

Current Biology

Volumn 6, Issue 11, 1996, Pages 1519-1527

  Sawai, Earl T ^a   Khan, Imran H ^a   Montbriand, Phillip M ^a   Peterlin, B Matija ^b   Cheng Mayer, Cecilia ^c   Luciw, Paul A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c AARON DIAMOND AIDS RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030292953     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(96)00757-9     Document Type: Article

References (47)

1. Cullen BR: The role of Nef in the replication cycle of the human and simian immunodeficiency viruses. Virology 1994, 205:1-6.
2. Ratner L, Niederman TMJ: Nef. Cur Top Micro Immunol 1995, 193:169-208.
3. Trono D: HIV accessory proteins: leading roles for the supporting cast. Cell 1995, 82:189-192.
4. Kestler HW, Ringler DJ, Mori K, Panicali DL, Sehgal PK, Daniel MD, et al.: Importance of the nef gene for maintenance of high virus loads and for the development of AIDS. Cell 1991, 65:651-662.
5. Baur AS, Sawai ET, Dazin P, Fantl WJ, Cheng-Mayer C, Peterlin BM: HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1994,1:373-384.
6. De SK, Marsh JW: HIV-1 Nef inhibits a common activation pathway in NIH-3T3 cells. J Biol Chem 1994, 269:6656-6660.
7. Greenway A, Azad A, McPhee D: Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. J Virol 1995, 69:1842-1850.
8. Skowronski J, Parks D, Mariani R: Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J 1993, 12:703-713.
9. Du Z, Lang SM, Sasseville VG, Lackner AA, Ilynskii PO, Daniel MD, et al.: Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell 1995, 82:665-674.
10. Aiken C, Konner J, Landau NR, Lenburg ME, Trono D: Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 1994, 76: 853-864.
11. Foster JL, Anderson SJ, Frazier AL, Garcia JV: Specific suppression of human CD4 surface expression by Nef from the pathogenic simian immunodeficiency virus SIVmac239open. Virology 1994, 201:373-379.
12. Garcia JV, Miller AD: Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 1991, 350:508-11.
13. Chowers MY, Spina CA, Kwoh TJ, Fitch NJ, Richman DD, Guatelli JC: Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J Virol 1994, 68:2906-2914.
14. Miller MD, Warmerdam MT, Gaston I, Greene WC, Feinberg MB: The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J Exp Med 1994, 179:101-113.
15. Miller MD, Warmerdam MT, Page KA, Feinberg MB, Greene WC: Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry. J Virol 1995, 69:579-584.
16. Harris MP, Neil JC: Myristoylation-dependent binding of HIV-1 Nef to CD4. J Mol Biol 1994, 241:136-142.
17. Collette Y, Dutartre H, Benziane A, Ramos-Morales F, Olive D: Physical and functional interaction of Nef with Lck -HIV-1 Nefinduced T-cell signaling defects. J Biol Chem 1996, 271:6333-6341.
18. Lee CH, Leung B, Lemmon MA, Zheng J, Cowburn D, Kuriyan J, et al.: A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J 1995, 14:5006-5015.
19. + viruses but not for down-regulation of CD4. EMBO J 1995, 14:484-491.
20. Benichou S, Bomsel M, Bodeus M, Durand H, Doute M, Letourneur F, et al.: Physical interaction of the HIV-1 Nef protein with β-COP, a component of non-clathrin-coated vesicles essential for membrane traffic. J Biol Chem 1994, 269:30073-30076.
21. Sawai ET, Baur A, Struble H, Peterlin BM, Levy JA, Cheng-Mayer C: Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proc Natl Acad Sci USA 1994, 91:1539-1543.
22. Sawai ET, Baur AS, Peterlin BM, Levy JA, Cheng-Mayer C: A conserved domain and membrane targeting of Neffrom HIV and SIV are required for association with a cellular serine kinase activity. J Biol Chem 1995, 270:15,307-15,314.
23. Manser E, Leung T, Salihuddin H, Zhao ZS, Lim L: A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 1994, 367:40-46.
24. Martin GA, Bollag G, McCormick F, Abo A: A novel serine kinase activated by rac1/CDC42Hs-dependent autophosphorylation is related to PAK65 and STE20. EMBO J 1995, 14:1970-1978.
25. Bagrodia S, Derijard B, Davis RJ, Cerione RA: Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogenactivated protein kinase activation. J Biol Chem 1995, 270:27995-27998.
26. Bagrodia S, Taylor SJ, Creasy CL, Chernoff J, Cerione RA: Identification of a mouse p21Cdc42/Rac activated kinase. J Biol Chem 1995, 270:22731-22737.
27. Brown JL, Stowers L, Baer M, Trejo J, Coughlin S, Chant J: Human Ste20 homologue hPAK1 links GTPases to the JNK MAP kinase pathway. Curr Biol 1996, 6:598-605.
28. Zhang S, Han J, Sells MA, Chernoff J, Knaus UG, Ulevitch RJ, et al.: Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J Biol Chem 1995, 270:23934-23936.
29. Knaus UG, Morris S, Dong HJ, Chernoff J, Bokoch GM: Regulation of human leukocyte p21-activated kinases through G protein-coupled receptors. Science 1995, 269:221-223.
30. Leung T, Manser E, Tan L, Lim L: A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes. J Biol Chem 1995, 270:290512904.
31. Pombo CM, Kehrl JH, Sanchez I, Katz P, Avruch J, Zon LI, et al.: Activation of the SAPK pathway by the human STE20 homologue germinal centre kinase. Nature 1996, 377:750-754.
32. Nunn MF, Marsh JW: Human immunodeficiency virus type 1 Nef associates with a member of the p21 -activated kinase family. J Virol 1996, 70: 6157-6161.
33. Burbelo PD, Drechsel D, Hall A: A conserved binding motif defines numerous candiate target proteins for both CDC42 and Rac GTPases. J Biol Chem 1995, 270:29071-29074.
34. Kestler H, Kodama T, Ringler D, Marthas M, Pedersen N, Lackner A, et al:. Induction of AIDS in rhesus monkeys by molecularly cloned simian immuno deficiency virus. Science 1990, 248:1109-1112.
35. Bukrinskaya AG, Ghorpade A, Heinzinger NK, Smithgall TE, Lewis RE, Stevenson M: Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. Proc Natl Acad Sci USA 1996, 93:367-371.
36. Gallay P, Swingler S, Aiken C, Trono D: HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 1995, 80:379-388.
37. Gallay P, Swingler S, Song J, Bushman F, Trono D: HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 1995, 83:569-576.
38. Pantaleo G, Fauci AS: New concepts in the immunopathogenesis of HIV infection. Annu Rev Immunol 1995, 13:487-512.
39. Whatmore AM, Cook N, Hall GA, Sharpe S, Rud EW, Cranage MP: Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence. J Virol 1995, 69:5117-5123.
40. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, et al:. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995, 270:988-991.
41. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC: Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. New Eng J Med 1995, 332:228-232.
42. Grzesiek G, Bax A, Clore GM, Gronenborn AM, Hu JS, Kaufman J, et al:. The solution structure of HIV-1 nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of hck tyrosine protein kinase. Nature Med 1996, 3:340-345.
43. Lee CH, Saksela K, Mirza UA, Chait BT, Kuriyan J: Crystal structure of the conserved core of HIV-1 nef complexed with a src family SH3 domain. Cell 1996, 85:931-942.
44. Luciw PA, Pratt-Lowe E, Shaw KE, Levy JA, Cheng-Mayer C: Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). Proc Natl Acad Sci USA 1995, 92:7490-7494.
45. Sawai ET, Butel JS: Association of a cellular heat shock protein with simian virus 40 large T antigen in transformed cells J Virol 1989,63:3961-3973.
46. Marthas ML, Ramos RA, Lohman BL, Van Rompay K, Unger RE, Miller CJ, et al.: Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac. J Virol 1993, 67:6047-6055.
47. Unger RE, Marthas ML, Lackner AA, Pratt LE, Lohman BL, Van RK, et al:. Detection of simian immunodeficiency virus DNA in macrophages from infected rhesus macaques. J Med Primatol 1992, 21:74-81.